Providing Intradialytic Parenteral Nutrition Therapy Does Not Improve Anthropometric Status in Hemodialysis Patients with Malnutrition
Abstract
Background: Malnutrition is prevalent in hemodialysis patients and significantly impacts prognosis. It can result from reduced food intake and protein loss during hemodialysis. Nutritional status is determined through anthropometric examinations, which include upper arm circumference (UAC), body mass index (BMI), hand grip strength, bicep, and tricep fold thickness. Laboratory examinations like total cholesterol and Malnutrition Inflammation Score (MIS) or Subjective Global Assessment (SGA) are also used. Intradialytic Parenteral Nutrition (IDPN) is expected to maintain or improve the nutritional status of hemodialysis patients.
Objective: This research examines the impact of parenteral nutrition therapy on the anthropometric status of malnourished hemodialysis patients.
Methods: This cross-sectional study, a sub-analysis of a larger nutritional therapy study, involved 24 hemodialysis patients experiencing malnutrition based on SGA B and C criteria with 1-10 years of hemodialysis. IDPN therapy was provided, and anthropometric measurements and total cholesterol were taken at baseline and three months after nutritional therapy. Data processing used comparative statistical analysis.
Results: The mean age was 45.33 years, with 14 males and 10 females. After 3 months, there were no significant differences in UAC (mean difference = 0.13; p = 0.69), BMI (mean difference = 0.13; p = 0.50), hand grip strength (mean difference = -0.96; p = 0.282), biceps skinfold thickness (mean difference = 0.13; p = 0.69) and triceps (mean difference = 0.59; p = 0.134) or total cholesterol (mean difference = -1.5; p = 0.71).
Conclusion: IDPN therapy for 3 months did not improve the anthropometric status of hemodialysis patients with malnutrition.
Downloads
References
V SM, Aguiar L, Dias C, Lourenço P, Pinheiro T, Velez B, et al. Predictors of nutritional and inflammation risk in hemodialysis patients. Clinical nutrition (Edinburgh, Scotland). 2020;39(6):1878-84.
Boaz M, Azoulay O, Schwartz IF, Schwartz D, Assady S, Kristal B, et al. Malnutrition Risk in Hemodialysis Patients in Israel: Results of the Status of Nutrition In Hemodialysis Patients Survey Study. Nephron. 2019;141(3):166-76.
Taziki O, Mohammad Alizadeh T, Alirezaei T. Mean Platelet Volume, Association with Inflammatory and Nutritional Markers in Maintenance Hemodialysis Patients. Iran J Kidney Dis. 2021;1(2):143-7.
Garcia-Torres R, Young L, Murray DP, Kheda M, Nahman NS, Jr. Dietary Protein Source and Phosphate Levels in Patients on Hemodialysis. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2020;30(5):423-9.
Prest MA, Parrott JS, Byham-Gray L. Test-Retest Reliability and Validity of the Nutrition-Specific Quality of Life Questionnaire. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2020;30(2):145-53.
Zhang Z, Yin D, Chen H, Liu B, Liu X, Shan W, et al. Evaluation of anemia, malnutrition, mineral, and bone disorder for maintenance hemodialysis patients based on bioelectrical impedance vector analysis (BIVA). Clin Exp Nephrol. 2020;24(12):1162-76.
Piccoli GB, Lippi F, Fois A, Gendrot L, Nielsen L, Vigreux J, et al. Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach. Nutrients. 2020;12(3).
Balbino KP, Juvanhol LL, Wendling AL, Marota LD, Costa JBS, Bressan J, et al. Dietary intake, clinical-nutritional status, and homocysteine in hemodialysis subjects: the mediating role of inflammation (NUGE-HD study). Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2020;45(8):845-50.
Komaba H, Kakuta T, Wada T, Hida M, Suga T, Fukagawa M. Nutritional status and survival of maintenance hemodialysis patients receiving lanthanum carbonate. Nephrol Dial Transplant. 2019;34(2):318-25.
Viramontes Hörner D, Selby NM, Taal MW. The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2019;29(2):149-55.
Leon JB, Albert JM, Gilchrist G, Kushner I, Lerner E, Mach S, et al. Improving Albumin Levels Among Hemodialysis Patients: A Community-Based Randomized Controlled Trial. American Journal of Kidney Diseases. 2006;48(1):28-36.
Kalantar-zadeh K. HHS Public Access. 2017;19(4):291-7.
Goldstein SL. Treatment and Biochemical Marker. 2005;15(3):312-7.
Iktzler TALP, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney International. 1994;46(3):830-7.
Capelli JP, Kushner H, Camiscioli TC, Chen S-m, Torres MA. Effect of Intradialytic Parenteral Nutrition on Mortality Rates in End-Stage Renal Disease Care. American Journal of Kidney Diseases. 1994;23(6):808-16.
Joannidis M, Rauchenzauner M, Leiner B, Rosenkranz A, Ebenbichler CF, Laimer M, et al. Effect of intradialytic parenteral nutrition in patients with malnutrition – inflammation complex syndrome on body weight, inflammation, serum lipids, and adipocytokines: results from a pilot study. 2008:789-95.
Anderson J. Evidence-based Synthesis Program Evidence Brief: Use of Intradialytic Parenteral Nutrition ( IDPN ) to Treat Malnutrition in Hemodialysis Patients. 2018.
Tsai YW, Chan YL, Chen YC, Cheng YH, Chang SS. Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease: A population-based study in Taiwan. Medicine (Baltimore). 2018 Sep;97(36):e11896. doi: 10.1097/MD.0000000000011896. PMID: 30200074; PMCID: PMC6133564.
Gurlek Demirci, B, Carrero, JJ, Tutal, E, Bal, Z, Sezer, S. Effect of nutritional support on nutritional status and inflammation in malnourished patients undergoing maintenance hemodialysis. Hemodialysis International. 2021; 25: 532– 540. https://doi.org/10.1111/hdi.12936
Copyright (c) 2024 Indonesian Journal of Kidney and Hypertension
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:
- Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.